.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
UBS
Express Scripts
US Department of Justice
Farmers Insurance
Medtronic
AstraZeneca
Harvard Business School
Cipla
Julphar

Generated: December 18, 2017

DrugPatentWatch Database Preview

POTASSIUM CITRATE Drug Profile

« Back to Dashboard

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ut Sw MedctrPOTASSIUM CITRATEpotassium citrateFOR SOLUTION;ORAL019647-002Oct 13, 1988DISCNYesNo► Subscribe► Subscribe► Subscribe
Strides PharmaPOTASSIUM CITRATEpotassium citrateTABLET, EXTENDED RELEASE;ORAL206813-003Sep 11, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Impax Labs IncPOTASSIUM CITRATEpotassium citrateTABLET, EXTENDED RELEASE;ORAL077440-002Jun 9, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa IncPOTASSIUM CITRATEpotassium citrateTABLET, EXTENDED RELEASE;ORAL203546-001Aug 6, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Ut Sw MedctrPOTASSIUM CITRATEpotassium citrateFOR SOLUTION;ORAL019647-001Oct 13, 1988DISCNYesNo► Subscribe► Subscribe► Subscribe
Impax Labs IncPOTASSIUM CITRATEpotassium citrateTABLET, EXTENDED RELEASE;ORAL077440-001Jun 9, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Strides PharmaPOTASSIUM CITRATEpotassium citrateTABLET, EXTENDED RELEASE;ORAL206813-002Sep 11, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Strides PharmaPOTASSIUM CITRATEpotassium citrateTABLET, EXTENDED RELEASE;ORAL206813-001Sep 11, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa IncPOTASSIUM CITRATEpotassium citrateTABLET, EXTENDED RELEASE;ORAL203546-003Aug 6, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa IncPOTASSIUM CITRATEpotassium citrateTABLET, EXTENDED RELEASE;ORAL203546-002Aug 6, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Accenture
Baxter
McKesson
Dow
Johnson and Johnson
Citi
Fish and Richardson
Boehringer Ingelheim
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot